Alchemab Therapeutics

0 followers


Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.

Industries

Employees

11-50

Links

Org chart

Jane Osbourn
Chief Scientific Officer
Olivia Cavlan
Chief Corporate Development & Strategy Officer
Paul Varley
SVP, Development
Ralph Minter
SVP, Research
Alexander Hewitson
VP of Operations
Jake Galson
VP of Technology
Peter Catalano
Head of Finance
Jenny Howell
Head of Project & Portfolio Management
Donna Finch
Head of Translational & Clinical Sciences
Becky Eretta
Head Of Human Resources
Maureen West
Scientist
Olivia Snudden
Associate Project Manager
Ruth Jones
Scientist